We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BVXVW market cap is 0. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|
| ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.17M | -20.05M | -6.76M | -8.29M | -3.19M |
| Net Income | 566k | -3.7M | -8.19M | -9.42M | -3.52M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | USD ($) | |
| Total Revenue | 0 | 0 | 12.68M | 40k | 0 |
| Operating Income | -76.93M | -78.35M | -55.47M | -34.83M | -11.06M |
| Net Income | -87.54M | -109.19M | -4.46M | -39.98M | -5.8M |
| Quarter End | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|
| ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | USD ($) | |
| Total Assets | 99.36M | 87.83M | 94.72M | 95.54M | 23.29M |
| Total Liabilities | 129.95M | 149.14M | 73.92M | 79.37M | 28.1M |
| Total Equity | -30.59M | -61.3M | 20.8M | 16.17M | -4.81M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | USD ($) | |
| Total Assets | 105.84M | 115.75M | 56.91M | 99.6M | 27.07M |
| Total Liabilities | 137.05M | 180.8M | 71.51M | 76.27M | 28.83M |
| Total Equity | -31.22M | -65.05M | -14.6M | 23.33M | -1.76M |
| Quarter End | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|
| ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | USD ($) | |
| Operating | -13.23M | N/A | -3.86M | N/A | -3.06M |
| Investing | -3.16M | N/A | 15k | N/A | -6k |
| Financing | -314k | N/A | 41.82M | N/A | N/A |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | USD ($) | |
| Operating | -57.19M | -77.06M | -72.54M | -24.48M | -7.27M |
| Investing | -23.45M | -7.2M | -5.94M | -361k | -836k |
| Financing | 84.32M | 85.21M | 13.72M | 67.78M | 6.78M |
| Market Cap | 0 |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 0 |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 6 (70.59%) |
| Company Name | BiondVax Pharmaceuticals Ltd |
| Address |
jerusalem biopark, 2nd floor, hadassah ein kerem campus jerusalem, jerusalem 7403618 |
| Website | https://www.biondvax.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
